Skip to main content

MODULACION DE LA PLASTICIDAD SINAPTICA COM ESTRATEGIA TERAPEUTICA EN LA ENFERMEDAD DE HUNTINGTON

SAF2014-57160-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons

  • Martín-Ibáñez, Raquel
  • Pardo, Mónica
  • Giralt, Albert
  • Miguez, Andrés
  • Guardia, Inés
  • Marion-Poll, Lucile
  • Herranz, Cristina
  • Esgleas, M.
  • García-Díaz Barriga, Gerardo
  • Edel, Michael J.
  • Vicario-Abejón, Carlos
  • Alberch, Jordi
  • Girault, Jean-Antoine
  • Chan, S.
  • Kastner, P.
  • Canals, Josep María
© The Author(s)., Here, we unravel the mechanism of action of the Ikaros family zinc finger protein Helios (He) during the development of striatal medium spiny neurons (MSNs). He regulates the second wave of striatal neurogenesis involved in the generation of striatopallidal neurons, which express dopamine 2 receptor and enkephalin. To exert this effect, He is expressed in neural progenitor cells (NPCs) keeping them in the G1/G0 phase of the cell cycle. Thus, a lack of He results in an increase of S-phase entry and S-phase length of NPCs, which in turn impairs striatal neurogenesis and produces an accumulation of the number of cycling NPCs in the germinal zone (GZ), which end up dying at postnatal stages. Therefore, He−/− mice show a reduction in the number of dorso-medial striatal MSNs in the adult that produces deficits in motor skills acquisition. In addition, overexpression of He in NPCs induces misexpression of DARPP-32 when transplanted in mouse striatum. These findings demonstrate that He is involved in the correct development of a subset of striatopallidal MSNs and reveal new cellular mechanisms for neuronal development., This study was supported by grants from the Ministerio de Economıa y ́ Competitividad (BFU2010-19630 to C.V.-A.; SAF 2014-57160-R, to J. A.; SAF2015- 66505-R to J.M.C.), and Instituto de Salud Carlos III-Subdirección General de Evaluación, and European Regional Development Fund (ERDF) [CIBERNED, to J. A and C.V.-A.; and RETICS (RD12/0019/0002; Red de Terapia Celular), to J.M.C.], Spain; Generalitat de Catalunya (2014SGR-968 to J.A.); Fundació la Marató de TV3 (20140130/1 to J.A.); and CHDI Foundation (A-7332 to J.M.C.). M.P. was a fellow from the Generalitat de Catalunya, Spain and E.C. was a fellow of the Ministerio de Economía y Competitividad, Spain
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

  • Fernández-Santiago, Rubén
  • Martín-Flores, Núria
  • Antonelli, Francesca
  • Cerquera, Catalina
  • Moreno, Verónica
  • Bandres-Ciga, Sara
  • Manduchi, Elisabetta
  • Tolosa, Eduard
  • Singleton, Andrew B.
  • Moore, Jason H.
  • Martí, María-José
  • Ezquerra, Mario
  • Malagelada, Cristina
Special Issue: Focused Ultrasound in Parkinson's Disease., [Background] Single nucleotide polymorphisms (SNPs) in the α‐synuclein (SNCA ) gene are associated with differential risk and age at onset (AAO) of both idiopathic and Leucine‐rich repeat kinase 2 (LRRK2)‐associated Parkinson's disease (PD). Yet potential combinatory or synergistic effects among several modulatory SNPs for PD risk or AAO remain largely underexplored., [Objectives] The mechanistic target of rapamycin (mTOR ) signaling pathway is functionally impaired in PD. Here we explored whether SNPs in the mTOR pathway, alone or by epistatic interaction with known susceptibility factors, can modulate PD risk and AAO., [Methods] Based on functional relevance, we selected a total of 64 SNPs mapping to a total of 57 genes from the mTOR pathway and genotyped a discovery series cohort encompassing 898 PD patients and 921 controls. As a replication series, we screened 4170 PD and 3014 controls available from the International Parkinson's Disease Genomics Consortium., [Results] In the discovery series cohort, we found a 4‐loci interaction involving STK11 rs8111699, FCHSD1 rs456998, GSK3B rs1732170, and SNCA rs356219, which was associated with an increased risk of PD (odds ratio = 2.59, P < .001). In addition, we also found a 3‐loci epistatic combination of RPTOR rs11868112 and RPS6KA2 rs6456121 with SNCA rs356219, which was associated (odds ratio = 2.89; P < .0001) with differential AAO. The latter was further validated (odds ratio = 1.56; P = 0.046‐0.047) in the International Parkinson's Disease Genomics Consortium cohort., [Conclusions] These findings indicate that genetic variability in the mTOR pathway contributes to SNCA effects in a nonlinear epistatic manner to modulate differential AAO in PD, unraveling the contribution of this cascade in the pathogenesis of the disease. © 2019 International Parkinson and Movement Disorder Society, Funding Information; Fundació la Marató de TV3. Grant Number: 60510; Michael J. Fox Foundation for Parkinson's Research. Grant Numbers: Dyskinesia Challenge 2014, MJF_PPMI_10_001, PI044024; National Institutes of Health. Grant Number: LM010098; Secretaría de Estado de Investigación, Desarrollo e Innovación. Grant Number: SAF2014‐57160R and SAF2017‐88812R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Helios modulates the maturation of a CA1 neuronal subpopulation required for spatial memory formation

  • Giralt, Albert
  • Brito, Verónica
  • Pardo, Mónica
  • Rubio, S.E.
  • Marion-Poll, Lucile
  • Martín-Ibáñez, Raquel
  • Zamora-Moratalla, Alfonsa
  • Bosch, Carles
  • Ballesteros, J.J.
  • Blasco, E.
  • García-Torralba, A.
  • Pascual, Marta
  • Pumarola, M.
  • Alberch, Jordi
  • Ginés, Silvia
  • Martín, E.D.
  • Segovia, J.
  • Soriano, E.
  • Canals, Josep María
Currently, molecular, electrophysiological and structural studies delineate several neural subtypes in the hippocampus. However, the precise developmental mechanisms that lead to this diversity are still unknown. Here we show that alterations in a concrete hippocampal neuronal subpopulation during development specifically affect hippocampal-dependent spatial memory. We observed that the genetic deletion of the transcription factor Helios in mice, which is specifically expressed in developing hippocampal calbindin-positive CA1 pyramidal neurons (CB-CA1-PNs), induces adult alterations affecting spatial memory. In the same mice, CA3-CA1 synaptic plasticity and spine density and morphology in adult CB-CA1-PNs were severely compromised. RNAseq experiments in developing hippocampus identified an aberrant increase on the Visinin-like protein 1 (VSNL1) expression in the hippocampi devoid of Helios. This aberrant increase on VSNL1 levels was localized in the CB-CA1-PNs. Normalization of VSNL1 levels in CB-CA1-PNs devoid of Helios rescued their spine loss in vitro. Our study identifies a novel and specific developmental molecular pathway involved in the maturation and function of a CA1 pyramidal neuronal subtype., This study was supported by grants from the Ministerio de Economia y Competitividad (SAF 2014-57160-R to JA; BFU2017-88393-P, to EDM; SAF2016-76340R to ES; and SAF2015-66505-R to J.M.C;), Spain; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad and European Regional Development Fund (ERDF) [CIBERNED, to JA and ES; Fondo de Investigaciones Sanitarias (PI11/00704) to MP; and RETICS (RD16/0011/0011 to JCS; RD16/0011/0012 to JMC, Red de Terapia Celular), to JMC], Spain; Generalitat de Catalunya (2017SGR-1095 to JA, and 2017SGR-1408 to JMC), Spain; and ADVANCE(CAT) with the support of ACCIÓ (Catalonia Trade & Investment; Generalitat de Catalunya), the European Community under the Catalonian ERDF operational program 2014–2020], Spain and from Ministerio de Ciencia, Innovación y Universidades (RTI2018-094678-A-I00 to AG; RTI2018-099001-B-I00 to JMC). AG is a Ramón y Cajal fellow (RYC-2016-19466).